Health & BioTech Companies – Page 2

Public Israeli computational chemistry and biology company developing AI-driven small-molecule discovery tools for pharmaceutical and agricultural products, with a focused 2026 strategy centered on its ChemPass AI platform.

MSICS Pharma is an Israeli pharmaceutical startup developing naturally sourced, medical-grade psilocybin and the GMP production platform needed to supply clinical research. Its lead product, MSX-06, is being developed for PTSD, treatment-resistant depression, OCD, and other difficult mental-health indications, giving the company a direct resilience relevance while its clinical and regulatory claims remain early.

Privately held Israeli liquid-biopsy company developing and commercializing PCR-based epigenetic tests for non-invasive cancer detection, led by the commercially available Bladder EpiCheck assay and a lung-cancer development pipeline.

Electric Algae is a Haifa, Israel climate-tech startup commercializing a Technion-derived bioelectric system that harvests electrical current from macroalgae while coupling energy generation with seaweed agriculture. Its strategic relevance is primarily distributed energy, food, and water resilience rather than a demonstrated defense product.

Alma Lasers is an Israeli medical-device company whose Alma brand develops and sells laser, light, radiofrequency, plasma, ultrasound, and shockwave systems for medical aesthetics, dermatology, beauty, and selected surgical indications. It is a mature, wholly owned operating subsidiary of Sisram Medical, the Hong Kong-listed medical-aesthetics group majority-owned by Fosun Pharma.

Sight Diagnostics developed compact blood-analysis systems that use automated sample preparation, optical imaging and computer vision to produce rapid hematology results from small blood samples. Its later strategy broadened toward AI analysis of live immune-cell behavior, but public reporting indicates that the company suspended operations and was effectively closed in 2026.

ECOncrete (ECOncrete Tech Ltd) is an Israeli-founded marine construction-technology company whose bio-enhancing concrete admixtures, science-based surface textures, and engineered armor units turn seawalls, breakwaters, ports, and offshore-energy foundations into structurally durable 'living' infrastructure that recruits marine life while hardening critical coastlines.

CardioScale is an Israeli medical-device company whose patented CVRI (Cardio Vascular Reserve Index) turns a non-invasive arm-cuff measurement into an objective, seconds-long read on a patient's hemodynamic state and trajectory, flagging hidden circulatory deterioration before conventional vital signs go abnormal for trauma, hemorrhage, sepsis, and mass-casualty triage.

Outbrain is an open-web advertising technology business whose recommendation, contextual targeting, and predictive optimization products help publishers monetize attention and advertisers acquire customers. Following its 2025 combination with Teads, the Outbrain technology and Direct Response operations continue under the Teads brand.

Lamin BioTex is an early-stage Israeli advanced-materials startup commercializing recombinant lamin-protein fibers as a bio-inspired reinforcement for carbon- and glass-fiber composites, with the stated goal of making laminates markedly tougher and lighter for aerospace, automotive, defense, and sporting-goods applications.

Voyago is a London, Ontario mobility-services operating brand wholly owned by Transdev, providing public transit, paratransit, student transportation, non-emergency medical transportation, and charter services. It is a mature Canadian transport operator and acquired asset, not an independent venture-backed technology startup.